The binding stoichiometry of CIN85SH3 domain A and Cbl-b -: Jozic et al. reply

被引：3

作者：

Jozic, Daniela ^{[1
]}

Cardenes, Nayra ^{[2
]}

Deribe, Yonathan Lissanu ^{[3
]}

Moncalian, Gabriel ^{[2
]}

Hoeller, Daniela ^{[3
]}

Groemping, Yvonne ^{[4
]}

Dikic, Ivan ^{[3
]}

Rittinger, Katrin ^{[1
]}

Bravo, Jeronimo ^{[2
]}

机构：

[1] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England

[2] CNIO, Signal Transduct Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain

[3] Univ Frankfurt, Inst Biochem 2, Sch Med, D-60590 Frankfurt, Germany

[4] Max Planck Inst Med Res, Abt Biomol Mech, D-69120 Heidelberg, Germany

来源：

NATURE STRUCTURAL & MOLECULAR BIOLOGY | 2008年 / 15卷 / 09期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/nsmb0908-891

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：891 / 892

页数：3

共 33 条

[31] Reply to the Letter to the Editor concerning the comments of Dr. F. Meunier to the article Appl. Catal. B: Environ. 136-137 (2013) 225-238, Kalamaras et al., titled "The effect of La3+ -doping of CeO2 support on the water-gas shift reaction mechanism and kinetics over Pt/Ce1-xLaxO2-δ"
Efstathiou, Angelos M.
Petallidou, Klito C.
APPLIED CATALYSIS B-ENVIRONMENTAL, 2014, 152 : 439 - 443
[32] Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9
Sylvester, Richard
Gontero, Paolo
Oddens, Jorg
EUROPEAN UROLOGY, 2016, 69 (06) : E123 - E124
[33] Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean FP Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer
Lestingi, Jean F. P.
Quoc-Dien Trinh
Coelho, Rafael F.
Pontes, Jose, Jr.
Bastos, Diogo A.
Nahas, William C.
EUROPEAN UROLOGY, 2021, 79 (06) : E184 - E185

← 1 2 3 4 →